Record stringlengths 1 197k |
|---|
<|newrecord|> nctId: NCT06278246 id: 050/2021 briefTitle: Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography overallStatus: NOT_YET_RECRUITING date: 2024-02 date: 2029-02 date: 2029-02 date: 2024-02-26 date: 2024-02-26 name: Centre for Addiction and Mental Health class: OTHER briefS... |
<|newrecord|> nctId: NCT06278233 id: 2023/85-70 briefTitle: Bihemispheric Transcranial Direct Current Stimulation* on Speech Fluency acronym: TDCS overallStatus: RECRUITING date: 2024-02 date: 2024-06 date: 2024-09 date: 2024-02-26 date: 2024-02-26 name: Biruni University class: OTHER briefSummary: It will be determine... |
<|newrecord|> nctId: NCT06278220 id: Corneal HOA briefTitle: Scheimpflug Versus Placido-disc System in Evaluation of Corneal Higher-Order Aberrations overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2026-07 date: 2027-02 date: 2024-02-26 date: 2024-02-28 name: Assiut University class: OTHER briefSummary: Aim of... |
To assess the agreement between placido-based topographer (wavelight allegro topolyzer vario) and scheimpflug -based (Oculus Pentacam ) regard measuring corneal higher order aberrations before and after LASIK. conditions: Corneal Higher-order Aberrations studyType: OBSERVATIONAL observationalModel: OTHER timePerspectiv... |
<|newrecord|> nctId: NCT06278207 id: 22731 briefTitle: An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions acronym: FINEROD overallStatus: RECRUITING date: 2024-02-15 date: 2024-06-30 date: 2024-06-30 da... |
The researchers will also collect data on any other disease or medical condition in the participants and on other medications used while taking finerenone. |
The data will come from a network of commercial electronic health records (EHRs) and national claims data in Japan. They cover the period from July 1st, 2021 until September 2023. Only already available data is collected and studied. There are no required visits or tests in this study. conditions: Chronic Kidney Diseas... |
<|newrecord|> nctId: NCT06278194 id: 22.11.2023.589 briefTitle: Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment overallStatus: NOT_YET_RECRUITING date: 2024-03-15 date: 2024-07-15 date: 2024-11-15 date: 2024-02-26 date: 2024-02-26 name: Başakşehir Çam & Sakura City Hospital class: OTHER_GOV briefS... |
The radiofrequency thermocoagulation therapy is used to ablate the affected trigeminal nerve branch and some of patients complain of subjective masseter weakness after this procedure. |
In theoretical basis, muscles innervated by target nerve are affected from ablation procedure. In this study the primary aim is to evaluate the change of the masseter muscle thickness in patients treated by gasserian ganglion radiofrequency thermocoagulation. The results may also show possible functional effect of the ... |
<|newrecord|> nctId: NCT06278181 id: 2023/08/1545 briefTitle: Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon overallStatus: RECRUITING date: 2023-09-21 date: 2024-12-30 date: 2025-01-30 date: 2024-02-26 date: 2024-03-01 name: Karolinska Institutet class: OTHER name: University of Dschang name: European Fo... |
<|newrecord|> nctId: NCT06278168 id: CNR-IRIB-PRO-2024-002 briefTitle: Awareness Training in Children With Autism Spectrum Disorder. overallStatus: RECRUITING date: 2023-06-12 date: 2024-06-01 date: 2025-05-08 date: 2024-02-26 date: 2024-02-26 name: Istituto per la Ricerca e l'Innovazione Biomedica class: OTHER name: M... |
<|newrecord|> nctId: NCT06278155 id: CNR-IRIB-PRO-2024-001 briefTitle: Social Relations Training for Children With ASD overallStatus: RECRUITING date: 2023-04-17 date: 2025-01-15 date: 2025-04-28 date: 2024-02-26 date: 2024-02-26 name: Istituto per la Ricerca e l'Innovazione Biomedica class: OTHER name: Messina, Italy ... |
The training lasts between 6 and 12 months, with one or two weekly group meetings lasting forty-five minutes each. Before the start and at the end of the protocol, participants are assessed using the Vineland scale to evaluate their adaptive behaviors. |
The primary goal is to enable children with autism to develop meaningful social skills, providing them with concrete tools to interact more effectively and independently with their peers, thus improving their quality of life and social involvement. The protocol involves two distinct groups, experimental and control gro... |
The experimental group involves the use of a social robot that acts as a mediator in the interactions among participants. The role of the social robot is to facilitate, reinforce and support the participants' responses during the activities. The therapist coordinates with the social robot, helping to guide, reinforce a... |
In the control group, the therapist takes on the role of mediating interactions, helping and facilitating participants' responses. There is no involvement of a social robot; therefore,the therapist self acts directly to guide, reinforce and support the participants' social interactions. conditions: Autism conditions: A... |
<|newrecord|> nctId: NCT06278142 id: ERTELEME_1 briefTitle: Web-Based Cognitive Behavior Therapy for Procrastination overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-04 date: 2024-07 date: 2024-02-26 date: 2024-02-26 name: Anadolu University class: OTHER briefSummary: The main purpose of this study is to pres... |
<|newrecord|> nctId: NCT06278129 id: 4146 briefTitle: Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease acronym: MRI_SSHL/MD overallStatus: RECRUITING date: 2018-06-19 date: 2021-04-23 date: 2025-12-31 date: 2024-02-26 date: 2024-02-26 name: Fondazione... |
<|newrecord|> nctId: NCT06278116 id: 2024-ALIGNERSCLEANSIGN briefTitle: Comparison of Absorbance Values, Sensory Evaluations and Periodontal Effects of Five Different Products for Clean Aligners Cleansing overallStatus: RECRUITING date: 2024-03-01 date: 2024-06 date: 2024-06 date: 2024-02-26 date: 2024-03-05 name: Univ... |
<|newrecord|> nctId: NCT06278103 id: 2023PI113 briefTitle: Correlation Between Expression of Hormonal Receptors, Clinical Data, and Methylation Profile in Meningiomas (MethylRH-M) acronym: MethylRH-M overallStatus: ENROLLING_BY_INVITATION date: 2000-01-01 date: 2024-07-01 date: 2024-09-01 date: 2024-02-26 date: 2024-02... |
<|newrecord|> nctId: NCT06278090 id: AUDC briefTitle: Impact of Ursodeoxycholic Acid Treatment on the Gallbladder Polyp Evolution acronym: GALPOL overallStatus: NOT_YET_RECRUITING date: 2024-02 date: 2026-02 date: 2026-07 date: 2024-02-26 date: 2024-02-28 name: Instituto de Investigación Sanitaria de la Fundación Jimén... |
• Whether ursodeoxycholic acid could decrease the gallbladder polyp size and therefore spare unnecessary follow up or surgical interventions |
Participants will be managed according to the standard practice of the department they are attended: |
* According to the established practice in the Department of Surgery, patients that either do not have an indication for cholecystectomy or decline the offered intervention, and are subjects for a follow up, are usually prescribed Ursodeoxycholic Acid, at 10-15 mg/kg/day for at least 6 months. |
* According to the standard practice of Gastroenterology Department, patients are followed up according to the published guidelines. |
Researchers will compare the groups that receive or not ursodeoxycolic acid treatment to see if the polyp size evolution differs significantly. conditions: Gallbladder Polyp studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 36 type: ESTIMATED name: Ursodeoxycholic Acid Only Product... |
<|newrecord|> nctId: NCT06278077 id: C2104 id: 2022-003565-38 type: EUDRACT_NUMBER briefTitle: Neurexan - a Clinical Trial in Short-Term Insomnia Patients overallStatus: RECRUITING date: 2023-09-04 date: 2024-12-31 date: 2024-12-31 date: 2024-02-26 date: 2024-02-26 name: Biologische Heilmittel Heel GmbH class: INDUSTRY... |
Participants will take either Neurexan or the placebo for 14 days. Sleep efficiency will be evaluated using PSG before and after the treatment period. Additionally, sleep quality-related factors will be investigated using PSG data, sleep diaries, and participant-completed questionnaires. |
The study will also investigate Neurexan's impact on stress levels. This will be assessed using the Cold Pressor Test, which measures stress through having the participant immerse their hand into ice water, and measuring changes in blood pressure and heart rate, both indicators of stress. In addition, blood and saliva ... |
Researchers will analyze data related to sleep efficiency, sleep quality, and stress symptoms. By comparing outcomes before and after Neurexan or placebo treatment, the study aims to detect improvements in these areas. Positive results with Neurexan but not with the placebo would provide robust evidence for Neurexan's ... |
<|newrecord|> nctId: NCT06278064 id: BFHHZML20240006 briefTitle: Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis overallStatus: RECRUITING date: 2024-02-01 date: 2024-12-31 date: 2025-06-30 date: 2024-02-26 date: 2024-02-26 name: Beijing Friendship Hospital class: OTHER briefSummary: This stu... |
<|newrecord|> nctId: NCT06278051 id: 21411 briefTitle: An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism overallStatus: RECRUITING date: 2024-02-19 date: 2024-12-31 date: 2024-12-31 date: 2024-02-26 date: 2024-04-18 name: Bayer class: INDU... |
Venous thromboembolism (VTE) is a condition in which people have problems due to the formation of blood clots in their veins. |
The study drug rivaroxaban is an approved treatment for VTE in children and adults in Japan. It is a blood thinner that prevents the blood from clotting by blocking a protein responsible for blood clotting. |
Warfarin is another blood thinner that is available for VTE. In this study warfarin is the reference drug. |
A previous study was carried out to learn about how well rivaroxaban works and how safe it is in children with VTE. However, to better understand the safety of this drug in children, more knowledge is needed about the use of rivaroxaban in the real world. |
The main purpose of this study is to learn more about the occurrence of major bleeding in children taking rivaroxaban. Major bleeding can be bleeding within the skull, bleeding inside the eye, bleeding from an organ in the digestive system, or bleeding which requires being given blood from a donor. |
In addition, this study will help learn more about the following in children with VTE: |
* The occurrence of major bleeding during treatment with rivaroxaban and during treatment with warfarin |
* The occurrence of bleeding of importance in children being treated with rivaroxaban and in children being treated with warfarin. Bleeding of importance in children can be: bleeding from the lung, blood in the kidney, heavy menstrual bleeding |
* The occurrence of major bleeding and bleeding of importance in children who are taking drugs called anti platelet agents and NSAIDs to prevent blood clots at the same time as rivaroxaban, who are taking a drug that blocks the action of a protein called 'CYP3A4' at the same time as rivaroxaban, who have reduced kidney... |
* The occurrence of repeated VTE on treatment with rivaroxaban and on treatment with warfarin The children with VTE in this study are already receiving rivaroxaban or warfarin treatment as part of their regular care from their doctors. |
The data will come from an electronic health records database created by a company called Medical Data Vision. The data will be collected between January 2021 and June 2024. |
Researchers will look at the health information from children less than 18 years of age with VTE in Japan who are prescribed treatment with rivaroxaban or warfarin during the study period. |
In this study, only available data from routine care are collected. No visits or tests are required as part of this study conditions: Venous Thromboembolism studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 100 type: ESTIMATED name: Rivaroxaban granules for oral suspension name: ... |
<|newrecord|> nctId: NCT06278038 id: NO.0057 in 2024 Ethical Review briefTitle: Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder overallStatus: NOT_YET_RECRUITING date: 2024-02-29 date:... |
<|newrecord|> nctId: NCT06278025 id: GO 19/833 briefTitle: Dysphagia and Deep Cervical Flexor Muscles overallStatus: COMPLETED date: 2019-09-01 date: 2024-02-01 date: 2024-02-01 date: 2024-02-26 date: 2024-03-18 name: Atılım University class: OTHER briefSummary: Cervical posture is vital for normal swallowing function.... |
<|newrecord|> nctId: NCT06278012 id: E-59394181-604.01.02-32288 briefTitle: Development of Atılım Kinesiophobia Scale overallStatus: RECRUITING date: 2024-01-01 date: 2024-03-30 date: 2024-03-30 date: 2024-02-26 date: 2024-04-01 name: Atılım University class: OTHER briefSummary: Background: |
Kinesiophobia or fear of movement, is defined as an excessive and irrational fear of physical movement to avoid painful injury, harm or re-injury. The existing scales measuring kinesiophobia are thought to have some limitations (the difficulty of patients to understand and answer the questions, the presence of question... |
Aim: The aim of this study is to develop and validate the Turkish Atılım Kinesiophobia Scale. |
Material/method: |
In the first stage of the study, research on kinesiophobia was reviewed and a total of 38 questions were created for the scale. The questions were submitted to the opinion of 11 experts working in the physiotherapy and rehabilitation field. Then A total of 100 patients with acute and chronic musculoskeletal pain comple... |
<|newrecord|> nctId: NCT06277999 id: D8820C00001 briefTitle: C.Difficile Observational Study overallStatus: NOT_YET_RECRUITING date: 2024-02-28 date: 2024-10-11 date: 2024-10-11 date: 2024-02-26 date: 2024-02-26 name: AstraZeneca class: INDUSTRY briefSummary: D8820C00001 is an exploratory, non-interventional, unblinded... |
<|newrecord|> nctId: NCT06277986 id: KY20212018-F-2 briefTitle: Early Diagnosis of Gastric Cancer Cachexia overallStatus: RECRUITING date: 2021-06-01 date: 2024-09-01 date: 2024-09-01 date: 2024-02-26 date: 2024-02-26 name: Xijing Hospital class: OTHER briefSummary: Gastric cancer is one of the most common malignancies... |
<|newrecord|> nctId: NCT06277973 id: 0007551-2 briefTitle: Feasibility Study of the Self-Care Immediate Stabilization Procedure (ISP) ® After a Traumatic Experience overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-01 date: 2025-05 date: 2024-02-26 date: 2024-03-27 name: Tel Aviv University class: OTHER briefS... |
Experiment group: |
Day 1 - questionnaires (T1) Day 4 - intervention Day 7 - questionnaires (T2) Day 97 - follow up questionnaires (T3) |
Waiting list group: |
Day 1 - questionnaires (T0) Day 7 - questionnaires (T1) Day 11- intervention Day 14- questionnaires (T2) Day 104- follow up questionnaires (T3) The parallel element of this model lies in the first week of the study: the experiment group goes through 2 measurements with the intervention in the middle of the week, wherea... |
<|newrecord|> nctId: NCT06277960 id: CNS2301 briefTitle: Septal Ablation for Obstructive HCM overallStatus: NOT_YET_RECRUITING date: 2024-02-29 date: 2024-06-30 date: 2024-11-30 date: 2024-02-26 date: 2024-02-26 name: SuZhou Sinus Medical Technologies Co.,Ltd class: INDUSTRY briefSummary: Hypertrophic cardiomyopathy (H... |
Previous researches have shown that interventricular septal radiofrequency ablation could effectively reduce the left ventricular outflow tract pressure gradient (LVOTG), thereby treating obstructive hypertrophic cardiomyopathy (HOCM). This device is based on the same radiofrequency ablation energy principle, however, ... |
The purpose of this study is to evaluate the safety and efficacy of percutaneous intramyocardial septal ablation catheters in the treatment of obstructive hypertrophic cardiomyopathy. conditions: Hypertrophic Obstructive Cardiomyopathy (HOCM) studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE... |
<|newrecord|> nctId: NCT06277947 id: SYSKY-2024-096-01 briefTitle: Administration of Hyperthermic Intraperitoneal Chemotherapy in the General Ward acronym: GARD-HIPEC overallStatus: NOT_YET_RECRUITING date: 2024-02 date: 2024-12 date: 2025-05 date: 2024-02-26 date: 2024-02-26 name: Sun Yat-Sen Memorial Hospital of Sun ... |
<|newrecord|> nctId: NCT06277934 id: RGT001-075-203 briefTitle: A Study of RGT001-075 in Adult Patients With Obesity overallStatus: RECRUITING date: 2024-03-08 date: 2024-06 date: 2024-07 date: 2024-02-26 date: 2024-04-04 name: Regor Pharmaceuticals Inc. class: INDUSTRY briefSummary: This study is being conducted to ev... |
<|newrecord|> nctId: NCT06277921 id: 110-2 briefTitle: Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery acronym: ESOSTAT overallStatus: NOT_YET_RECRUITING date: 2024-03-18 date: 2024-09-18 date: 2024-12-31 date: 2024-02-26 date: 2024-02-26 name: P. Herzen Moscow Oncology Research Ins... |
However, esophagectomy for esophageal cancer is a complex procedure which carries high risk of morbidity rate of 24% and a mortality rate of 2% to 5.6%, respectively There is a need to study the differences of 90-day postoperative morbidity and mortality in different clinics and centers of the Russian Federation. condi... |
<|newrecord|> nctId: NCT06277908 id: 110-1 briefTitle: Postoperative Morbidity and Mortality After Gastric Cancer Surgery acronym: GASTROSTAT overallStatus: NOT_YET_RECRUITING date: 2024-03-18 date: 2024-09-18 date: 2024-12-31 date: 2024-02-26 date: 2024-02-26 name: P. Herzen Moscow Oncology Research Institute class: O... |
<|newrecord|> nctId: NCT06277895 id: KYLL-202401-047 briefTitle: VOCs in Patients With Acute Cardiogenic Chest Pain overallStatus: RECRUITING date: 2024-01-26 date: 2024-12-31 date: 2024-12-31 date: 2024-02-26 date: 2024-02-26 name: Qilu Hospital of Shandong University class: OTHER briefSummary: The goal of this observ... |
1. VOCs levels were measured at baseline in healthy people, and markers of VOCs that could be used to identify acute cardiogenic chest pain were sought. |
2. The relationship between abnormal VOCs (mainly aldehydes) and prognosis of patients and the correlation with Super-score for early warning of acute heart failure. conditions: Acute Coronary Syndrome conditions: Acute Aortic Syndrome studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: P... |
<|newrecord|> nctId: NCT06277882 id: Si 067/2024 briefTitle: Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis overallStatus: RECRUITING date: 2024-02-29 date: 2025-03-01 date: 2025-05-31 date: 2024-02-26 date: 2024-03-19 name: Mahidol University class: OTHER briefSumma... |
However, HAV infection in patients with chronic liver disease, especially those over 50 years old, may result in more severe outcomes, including fulminant hepatitis, with a higher mortality rate compared to the general population |
HAV vaccination is a cornerstone of prevention, especially in high-risk groups. Currently, there is a recommendation to vaccinate patients with chronic liver disease against HAV infection. However, these patients often have compromised immune responses, leading to lower vaccine efficacy compared to the general populati... |
The goal of this randomized controlled trial is to compare the efficacy and safety of the standard 2-dose (0, 6 months) hepatitis A vaccination regimen with an intensive 3-dose (0, 1, 6 months) schedule in patients with advanced fibrosis and cirrhosis. |
The main questions it aims to answer are: |
* Compared the seroconversion rate of the standard 2-dose (0, 6 months) hepatitis A vaccination regimen versus the intensive 3-dose (0, 1, 6 months) hepatitis A vaccination regimen in patients with advanced fibrosis and cirrhosis. |
* Compared the antibody levels against the hepatitis A virus (Anti-HAV IgG) of the standard 2-dose (0, 6 months) hepatitis A vaccination regimen versus the intensive 3-dose (0, 1, 6 months) hepatitis A vaccination regimen in patients with advanced fibrosis and cirrhosis. conditions: Cirrhosis conditions: Hep A conditio... |
<|newrecord|> nctId: NCT06277869 id: PR-22146 briefTitle: Effectiveness Trial of Thermal Jacket overallStatus: RECRUITING date: 2024-03-01 date: 2024-12-22 date: 2024-12-31 date: 2024-02-26 date: 2024-03-07 name: International Centre for Diarrhoeal Disease Research, Bangladesh class: OTHER name: Bangabandhu Sheikh Muji... |
Maintaining continuous Kangaroo Mother Care (KMC) for at least 16-20 hours/day, is sometimes not feasible for mothers or caregivers. In addition, we also have the challenge of keeping preterm or low birthweight (LBW) neonates warm during transportation. |
The scientists at icddr,b, Johns Hopkins University, and George Mason University developed the thermal jacket for keeping preterm or LBW neonate warm. We have already completed the laboratory trial on mannquins and clinical safety trial among preterm or LBW neonates. Now, we propose to build on our previous work by sys... |
Hypothesis: Thermal jacket can increase the rate of euthermia among the preterm or LBW neonates in the selected health facilities in Bangladesh. |
Objectives: The aim of this study is to test whether the thermal jacket can attain and maintain euthermia of preterm or LBW neonates in clinical settings of Bangladesh. conditions: Preterm Neonate conditions: Low Birthweight Neonate studyType: INTERVENTIONAL phases: PHASE2 allocation: NON_RANDOMIZED interventionModel: ... |
<|newrecord|> nctId: NCT06277856 id: Aysun Eksioglu id: Ayse Akyar type: OTHER domain: Ege University briefTitle: Peer Interaction of Primiparas Sharing a Room With Multiparas With Successful Breastfeeding Experience overallStatus: RECRUITING date: 2023-09-15 date: 2024-06-15 date: 2024-09-15 date: 2024-02-26 date: 202... |
Overall, this research aims to improve breastfeeding rates by implementing peer support programs in hospital settings and evaluating the outcomes of peer interactions in terms of the mother's breastfeeding self-efficacy and attitudes towards breastfeeding. conditions: Mothers studyType: INTERVENTIONAL phases: NA alloca... |
<|newrecord|> nctId: NCT06277843 id: PR-21131 briefTitle: Low-Cost and Reusable Thermal Jacket for Managing Preterm or Low Birth Weight Neonates. overallStatus: COMPLETED date: 2022-06-13 date: 2022-09-01 date: 2022-09-30 date: 2024-02-26 date: 2024-02-26 name: International Centre for Diarrhoeal Disease Research, Bang... |
Maintaining continuous KMC for at least 16-20 hours/day, is sometimes not feasible for mothers or caregivers. In addition, we also have the challenge of keeping preterm or LBW neonates warm during transportation. |
The scientists at icddr,b, Johns Hopkins University, and George Mason University developed the re-usable thermal jacket for keeping preterm or low-birth-weight neonate warm. We propose to build on previous work by systematically testing the safety of the 'thermal jacket' among preterm or low birthweight (LBW) neonates. |
Objective of this study is to conduct clinical safety trial of the thermal jacket to test whether the thermal jacket can retain euthermia of preterm or LBW neonates for 2 hours. conditions: Preterm conditions: Low Birthweight conditions: Hypothermia Neonatal studyType: INTERVENTIONAL phases: EARLY_PHASE1 allocation: NA... |
<|newrecord|> nctId: NCT06277830 id: 2023P002788 briefTitle: Physical Activity Monitoring in Myasthenia Gravis overallStatus: RECRUITING date: 2024-02-14 date: 2024-06 date: 2024-06 date: 2024-02-26 date: 2024-03-04 name: Massachusetts General Hospital class: OTHER name: BioSensics briefSummary: The goal of this observ... |
The main question\[s\] it aims to answer are: |
* To measure the correlation of sensor-based measures of motor function with existing outcome measures including the MG-ADL, MGQOL15r, QMG, MGComposite, and Neuro-QOL Fatigue scales. |
* To develop and validate tablet-based digital assessments of speech and facial expression and to compare with existing outcome measures. |
Participants will wear a pendant sensor for 7 days and then participate in tablet-based and in-person myasthenia-specific physical examinations. This will be performed in concert with routine care in the Massachusetts General Hospital MG clinic. conditions: Myasthenia Gravis studyType: OBSERVATIONAL observationalModel:... |
<|newrecord|> nctId: NCT06277817 id: 2021/1916 briefTitle: The Effect of Chest Physiotherapy Methods Applied Before Aspiration on Respiratory Characteristics overallStatus: COMPLETED date: 2021-05-19 date: 2021-06-25 date: 2022-10-24 date: 2024-02-26 date: 2024-02-26 name: Inonu University class: OTHER briefSummary: Ph... |
<|newrecord|> nctId: NCT06277804 id: LTC004-102 briefTitle: A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2027-07-01 date: 2027-07-01 date: 2024-02-26 date: 2024-02-26 name: Letolab class: INDUSTRY briefSummary: ... |
<|newrecord|> nctId: NCT06277791 id: HStomatologyWuhan1 briefTitle: The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma overallStatus: RECRUITING date: 2023-08-19 date: 2024-07-31 date: 2025-07-31 date: 2024-02-26 date: 2024-02-26 name: Hospital ... |
• \[Observing the effectiveness and safety of the combination of Adebrelimab and TP regimen in neoadjuvant therapy for clinical IVB stage oral squamous cell carcinoma patients\] Participants will \[Received treatment with Adebrelimab combined with TP regimen, followed by surgery after 2 cycles of neoadjuvant therapy. A... |
<|newrecord|> nctId: NCT06277778 id: HSEARS20211117003-03 briefTitle: Effect of Combined Music and Taekwondo Training for Children With Autism Spectrum Disorder overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2026-06-30 date: 2026-12-31 date: 2024-02-26 date: 2024-02-26 name: The Hong Kong Polytechnic Universi... |
<|newrecord|> nctId: NCT06277765 id: CM310-101212 briefTitle: Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis overallStatus: NOT_YET_RECRUITING date: 2024-05-30 date: 2025-05-30 date: 2025-05-30 date: 2024-02-26 date: 2024-02-26 name: Keymed Biosciences Co.Ltd class: INDUSTRY briefSummary: This is ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.